Developer docs
API playgroundTry for free, no card

Search company profiles

American Oncology Institute

Full company profile

uuid002bq35

Namestring
American Oncology Institute
Legal namestring
Cancer Treatment Services International (CTSI)
Company typeenum
Private
Founded yearint
2012
Descriptiontext

American Oncology Institute (AOI) is a multi-disciplinary oncology hospital network operating 17 cancer treatment facilities across India and Sri Lanka, with corporate headquarters in Hyderabad. The chain provides comprehensive cancer care spanning radiation oncology, medical oncology, surgical oncology, hemato-oncology and bone marrow transplantation (BMT), pediatric hemato-oncology, nuclear medicine, palliative medicine, pain management, and clinical oncology. AOI's geographic footprint covers 16 Indian cities (tier-2/3 markets such as Hisar, Jammu, Jalandhar, Ludhiana, Aligarh, Imphal, Nagpur, Coimbatore, and Guntur alongside metros Hyderabad and Gurugram) and one facility in Colombo, Sri Lanka, positioning it as the largest and fastest-growing dedicated oncology network in South Asia.

The platform is built on US university-standardized clinical protocols implemented through a Centralized Treatment Planning function and reviewed by an International Tumor Board. Its technology stack includes robotic-assisted surgery featuring a Triple ICG (Indocyanine Green) Fluorescence-Guided technique for esophageal cancer resections, and PET-CT imaging deployed at 12+ hospital locations for diagnosis, staging, and treatment monitoring. Service lines are supported by a diagnostic imaging suite, cancer screening programs, second opinion services, and online consultations, with the combination of standardized SOPs, advanced hardware, and multi-disciplinary case review serving as the basis of clinical differentiation against standalone oncology practices.

AOI operates a direct-to-patient fee-for-service model, with revenue generated from treatment delivery, diagnostics, surgical procedures, and BMT. Patient acquisition runs through a multi-channel mix including a 24/7 call center, WhatsApp support, online appointment booking, second-opinion requests, cancer screening campaigns, and a dedicated international patient services vertical. AOI is a wholly-owned subsidiary of Cancer Treatment Services International (CTSI), itself a subsidiary of Varian Medical Systems Inc., in turn owned by Siemens Healthineers. Siemens is currently running a divestiture process for AOI at a deal value of ₹1,500-2,000 crore with Alvarez & Marsal advising, and non-binding bids expected by end of June.

Short descriptiontext

American Oncology Institute operates 17 multi-disciplinary cancer hospitals across India and Sri Lanka, delivering radiation, medical, surgical, and hemato-oncology services under US-standardized clinical protocols. The chain is owned by Siemens Healthineers (via CTSI/Varian) and is currently being divested at a ₹1,500-2,000 crore valuation.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersHyderabad, India
HQ citystring
Hyderabad
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices18 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cancer treatment services, oncology hospital network, radiation oncology, medical oncology, bone marrow transplant
Industry5 codes
1Oncology & Cancer Specialty Hospitals
CodeHLAFAHACPrimaryYes
2Medical Oncology
CodeHLAKAFABPrimaryNo
3Radiation Oncology
CodeHLAKAFACPrimaryNo
4Surgical Oncology
CodeHLAKAFAGPrimaryNo
5Oncology Telemedicine Platforms
CodeHLALAGAHPrimaryNo
NAICS code1 code
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
SIC code2 codes
  • Services-Hospitals8060
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Oncology Hospital Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Cancer Treatment Services
TypeProfessional Services
Description

Direct healthcare service delivery through hospital network offering oncology treatments including radiation therapy, chemotherapy, surgical oncology, stem cell transplants, and related medical services

americanoncology.com
2Diagnostic Services
TypeProfessional Services
Description

PET-CT scans, pathology, imaging, and laboratory diagnostic services across hospital locations

americanoncology.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

American Oncology Institute (AOI) operates a multi-disciplinary oncology hospital network across South Asia, delivering comprehensive cancer diagnosis, treatment, and supportive care through 17 hospitals in India and Sri Lanka. Core offerings span radiation oncology, medical oncology, surgical oncology, hemato-oncology and bone marrow transplant, nuclear medicine, palliative care, and pain management. Services are delivered under US university-standardized clinical protocols, with centralized treatment planning, an International Tumor Board for complex cases, and advanced technologies including PET-CT imaging and robotic-assisted surgery.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Real-time tumor visualization enabling more precise tumor resections with enhanced safety and oncological outcomes
Product overview1 text field

American Oncology Institute (AOI) operates a multi-disciplinary oncology hospital network across South Asia, offering comprehensive cancer care through 17 hospitals in India and Sri Lanka. The platform provides an integrated suite of treatment services including Radiation Oncology, Medical Oncology, Surgical Oncology (with advanced robotic surgery capabilities), Hemato Oncology & BMT, Nuclear Medicine, and PET-CT diagnostic imaging across all locations. AOI differentiates itself through international treatment protocols aligned with US university standards, centralized treatment planning, and multi-disciplinary tumor boards. The organization functions as a subsidiary of Cancer Treatment Services Hyderabad (CTSH), which is part of Varian Medical Systems Inc (a Siemens Healthineers company), with services spanning from preventive screening and second opinions through advanced surgical and medical treatments to palliative care.

Product and service16 records
1Radiation Oncology
CategoryRadiation Therapy
Description

Cancer treatment using high-energy radiation to target and destroy cancer cells' DNA, applicable across multiple cancer types including breast, head and neck, cervical, and prostate cancers. Targeted at patients requiring radiation-based oncology care.

2Medical Oncology
CategoryMedical Oncology / Systemic Therapy
Description

Chemotherapy and targeted therapy services for cancer treatment, including immunotherapy and hormonal therapy delivered by medical oncologists. Targeted at patients with solid tumors and hematologic malignancies.

3Surgical Oncology
CategorySurgical Oncology
Description

Surgical interventions for tumor removal including robotic-assisted surgeries, with capabilities for complex procedures such as robotic esophagectomy. Targeted at patients requiring surgical resection of tumors.

4Hemato Oncology & BMT
CategoryHemato-Oncology and Bone Marrow Transplant
Description

Blood cancer treatment including leukemia, lymphoma, myeloma along with bone marrow transplantation services for adults and pediatric patients. Targeted at patients with hematologic malignancies requiring bone marrow transplant.

5Paediatric Hemato Oncology & BMT
CategoryPediatric Hemato-Oncology and Bone Marrow Transplant
Description

Specialized cancer care and bone marrow transplantation for pediatric patients with blood cancers and related conditions. Targeted at children with hematologic malignancies.

6Nuclear Medicine
CategoryNuclear Medicine / Diagnostic Imaging
Description

Diagnostic imaging services including PET-CT scans for cancer detection, staging, and treatment planning across multiple hospital locations. Targeted at patients requiring advanced imaging for cancer diagnosis.

7PET-CT Scan Services
CategoryDiagnostic Imaging / PET-CT
Description

Positron Emission Tomography combined with CT scanning for cancer diagnosis, staging, and treatment monitoring available at multiple AOI locations. Targeted at cancer patients and referring physicians needing advanced imaging.

8Pain Management
CategorySupportive Care
Description

Specialized pain management services for cancer patients to address treatment-related pain and improve quality of life. Targeted at cancer patients experiencing pain from disease or treatment.

9Palliative Medicine
CategorySupportive Care / Palliative Care
Description

Palliative care services focused on symptom management and quality of life improvement for advanced cancer patients. Targeted at patients with advanced-stage disease requiring end-of-life and symptom-focused care.

10Clinical Oncology
CategoryClinical Oncology
Description

Comprehensive clinical oncology services providing diagnosis, treatment planning, and management across all cancer types. Targeted at patients seeking end-to-end oncology clinical management.

11Anaesthesia & Critical Care
CategoryAnaesthesia and Critical Care
Description

Anaesthesia and critical care services supporting complex oncology surgeries and ICU-level patient management. Targeted at patients undergoing major surgical oncology procedures and those requiring intensive care.

12Cancer Screening Services
CategoryPreventive Care / Cancer Screening
Description

Early detection and screening services for various cancer types to identify cancer at initial stages when treatment is most effective. Targeted at asymptomatic individuals and at-risk populations for preventive screening.

13Second Opinion Service
CategoryConsultation Service
Description

Expert second opinion consultations for cancer diagnosis and treatment planning, allowing patients to secure their health decisions with additional specialist input. Targeted at patients seeking confirmation or alternative treatment recommendations.

14Online Consultation
CategoryDigital Health / Teleconsultation
Description

Digital consultation services allowing patients to connect with AOI oncologists remotely for initial assessments and follow-up consultations. Targeted at patients seeking remote specialist access.

15International Patient Services
CategoryMedical Tourism / International Patient Coordination
Description

Specialized services for international patients seeking cancer treatment in India, including treatment planning and coordination. Targeted at cross-border medical tourists seeking affordable, internationally-standardized oncology care.

16Triple ICG Fluorescence-Guided Robotic Surgery
CategoryAdvanced Surgical Oncology / Robotic Surgery
Description

Advanced robotic esophageal cancer surgery technique integrating Indocyanine Green (ICG) fluorescence navigation with robotic technology, providing real-time visualization of tumors, blood supply, and anatomical structures for precise tumor resections. Targeted at esophageal cancer patients requiring high-precision surgical oncology.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierSupportingTypeOthersAnnounced on2026-05-13
Description

Investment bank engaged by Siemens Healthineers to advise on the planned exit from American Oncology Institute, valued at ₹1,500-2,000 crore

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major multi-specialty tertiary care hospital group with established cancer care programs including radiation oncology, surgical oncology, and BMT. Competes for complex oncology referrals in North India, with overlapping clinical capabilities but broader specialty mix than AOI.

TypeBroad incumbent
Description

One of India's largest hospital networks with multi-city presence and oncology service lines. Overlaps with AOI in metro and Tier-2 footprint and cancer care capabilities, but operates as a broad-spectrum health system rather than an oncology specialist.

TypeBroad incumbent
Description

Large multi-specialty hospital network in India with established oncology departments across multiple cities. Competes with AOI for cancer referrals, particularly in North India (Punjab, Haryana, NCR), but oncology is part of a broader hospital portfolio rather than the company's specialty focus.

TypeBroad incumbent
Description

Large multi-specialty hospital chain with growing oncology services including the Mazumdar Shaw Cancer Centre. Competes with AOI on complex cancer care and price-value positioning, particularly in South India, though cancer is one of multiple specialties within a broader network.

TypeBroad incumbent
Description

Leading North India multi-specialty hospital chain with a dedicated oncology program serving the same geographies as AOI (Delhi NCR, Punjab, Haryana). Comparable on cancer care delivery, technology, and patient demographics, though oncology is one of several verticals.

TypeBroad incumbent
Description

India's largest multi-specialty hospital chain with comprehensive oncology programs across many cities. Overlaps with AOI in radiation, medical, and surgical oncology and competes for the same complex cancer referrals, but operates as a broad incumbent rather than a cancer-only specialist.

TypeBroad incumbent
Description

Multi-geography hospital and clinic operator with material India presence including oncology offerings. Comparable on hospital-based specialty care delivery and outpatient oncology revenue mix, but operates across multiple countries and verticals rather than focusing on cancer specialty.

TypeDirect peer
Description

A focused oncology hospital chain in India providing multi-disciplinary cancer care (medical, surgical, radiation, hemato-oncology) with an organ-site specialty approach. Comparable to AOI as a specialty-only oncology network targeting similar patient segments and complexity tier.

TypeBroad incumbent
Description

Premier government-subsidized cancer specialty hospital in India, widely considered the gold standard for oncology care. Sets clinical reference protocols for the Indian oncology ecosystem and is a credible alternative to AOI, particularly for cost-sensitive patients, though operates on a public-subsidy model rather than for-profit commercial model.

TypeDirect peer
Description

India's largest dedicated oncology hospital chain operating a multi-city network of cancer specialty hospitals with radiation, medical, and surgical oncology plus diagnostics. HCG is the closest direct competitor and has been approached as a strategic bidder for AOI, making it the most analogous operating model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

American Oncology Institute

Oncology Hospital Servicesamericanoncology.com

American Oncology Institute operates 17 multi-disciplinary cancer hospitals across India and Sri Lanka, delivering radiation, medical, surgical, and hemato-oncology services under US-standardized clinical protocols. The chain is owned by Siemens Healthineers (via CTSI/Varian) and is currently being divested at a ₹1,500-2,000 crore valuation.

What American Oncology Institute does

American Oncology Institute (AOI) is a multi-disciplinary oncology hospital network operating 17 cancer treatment facilities across India and Sri Lanka, with corporate headquarters in Hyderabad. The chain provides comprehensive cancer care spanning radiation oncology, medical oncology, surgical oncology, hemato-oncology and bone marrow transplantation (BMT), pediatric hemato-oncology, nuclear medicine, palliative medicine, pain management, and clinical oncology. AOI's geographic footprint covers 16 Indian cities (tier-2/3 markets such as Hisar, Jammu, Jalandhar, Ludhiana, Aligarh, Imphal, Nagpur, Coimbatore, and Guntur alongside metros Hyderabad and Gurugram) and one facility in Colombo, Sri Lanka, positioning it as the largest and fastest-growing dedicated oncology network in South Asia.

The platform is built on US university-standardized clinical protocols implemented through a Centralized Treatment Planning function and reviewed by an International Tumor Board. Its technology stack includes robotic-assisted surgery featuring a Triple ICG (Indocyanine Green) Fluorescence-Guided technique for esophageal cancer resections, and PET-CT imaging deployed at 12+ hospital locations for diagnosis, staging, and treatment monitoring. Service lines are supported by a diagnostic imaging suite, cancer screening programs, second opinion services, and online consultations, with the combination of standardized SOPs, advanced hardware, and multi-disciplinary case review serving as the basis of clinical differentiation against standalone oncology practices.

AOI operates a direct-to-patient fee-for-service model, with revenue generated from treatment delivery, diagnostics, surgical procedures, and BMT. Patient acquisition runs through a multi-channel mix including a 24/7 call center, WhatsApp support, online appointment booking, second-opinion requests, cancer screening campaigns, and a dedicated international patient services vertical. AOI is a wholly-owned subsidiary of Cancer Treatment Services International (CTSI), itself a subsidiary of Varian Medical Systems Inc., in turn owned by Siemens Healthineers. Siemens is currently running a divestiture process for AOI at a deal value of ₹1,500-2,000 crore with Alvarez & Marsal advising, and non-binding bids expected by end of June.

American Oncology Institute firmographics

Firmographics
Name
American Oncology Institute
Legal name
Cancer Treatment Services International (CTSI)
Website
https://americanoncology.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
American Oncology Institute operates 17 multi-disciplinary cancer hospitals across India and Sri Lanka, delivering radiation, medical, surgical, and hemato-oncology services under US-standardized clinical protocols. The chain is owned by Siemens Healthineers (via CTSI/Varian) and is currently being divested at a ₹1,500-2,000 crore valuation.
Ownership category
akta.pro rank

American Oncology Institute industry classification

Industry
Product category
Oncology Hospital Services
NAICS
Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)
SIC
Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro primary industry
Oncology & Cancer Specialty Hospitals (HLAFAHAC)
akta.pro secondary industries
Medical Oncology (HLAKAFAB), Radiation Oncology (HLAKAFAC), Surgical Oncology (HLAKAFAG), Oncology Telemedicine Platforms (HLALAGAH)

Keywords

  • Cancer treatment services
  • Oncology hospital network
  • Radiation oncology
  • Medical oncology
  • Bone marrow transplant

Where American Oncology Institute is headquartered

Location

Headquarters

HQ city
Hyderabad
HQ country
India
HQ region
Asia

Offices18 records

Markets served

American Oncology Institute business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. Cancer Treatment Services: Direct healthcare service delivery through hospital network offering oncology treatments including radiation therapy, chemotherapy, surgical oncology, stem cell transplants, and related medical services
  2. Diagnostic Services: PET-CT scans, pathology, imaging, and laboratory diagnostic services across hospital locations

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

American Oncology Institute product offering

Product offering

Core offering

American Oncology Institute (AOI) operates a multi-disciplinary oncology hospital network across South Asia, delivering comprehensive cancer diagnosis, treatment, and supportive care through 17 hospitals in India and Sri Lanka. Core offerings span radiation oncology, medical oncology, surgical oncology, hemato-oncology and bone marrow transplant, nuclear medicine, palliative care, and pain management. Services are delivered under US university-standardized clinical protocols, with centralized treatment planning, an International Tumor Board for complex cases, and advanced technologies including PET-CT imaging and robotic-assisted surgery.

Product overview

American Oncology Institute (AOI) operates a multi-disciplinary oncology hospital network across South Asia, offering comprehensive cancer care through 17 hospitals in India and Sri Lanka. The platform provides an integrated suite of treatment services including Radiation Oncology, Medical Oncology, Surgical Oncology (with advanced robotic surgery capabilities), Hemato Oncology & BMT, Nuclear Medicine, and PET-CT diagnostic imaging across all locations. AOI differentiates itself through international treatment protocols aligned with US university standards, centralized treatment planning, and multi-disciplinary tumor boards. The organization functions as a subsidiary of Cancer Treatment Services Hyderabad (CTSH), which is part of Varian Medical Systems Inc (a Siemens Healthineers company), with services spanning from preventive screening and second opinions through advanced surgical and medical treatments to palliative care.

Differentiator

Problem solved

Functional benefit

Products and services

  • Radiation Oncology Cancer treatment using high-energy radiation to target and destroy cancer cells' DNA, applicable across multiple cancer types including breast, head and neck, cervical, and prostate cancers. Targeted at patients requiring radiation-based oncology care.
  • Medical Oncology Chemotherapy and targeted therapy services for cancer treatment, including immunotherapy and hormonal therapy delivered by medical oncologists. Targeted at patients with solid tumors and hematologic malignancies.
  • Surgical Oncology Surgical interventions for tumor removal including robotic-assisted surgeries, with capabilities for complex procedures such as robotic esophagectomy. Targeted at patients requiring surgical resection of tumors.
  • Hemato Oncology & BMT Blood cancer treatment including leukemia, lymphoma, myeloma along with bone marrow transplantation services for adults and pediatric patients. Targeted at patients with hematologic malignancies requiring bone marrow transplant.
  • Paediatric Hemato Oncology & BMT Specialized cancer care and bone marrow transplantation for pediatric patients with blood cancers and related conditions. Targeted at children with hematologic malignancies.
  • Nuclear Medicine Diagnostic imaging services including PET-CT scans for cancer detection, staging, and treatment planning across multiple hospital locations. Targeted at patients requiring advanced imaging for cancer diagnosis.
  • PET-CT Scan Services Positron Emission Tomography combined with CT scanning for cancer diagnosis, staging, and treatment monitoring available at multiple AOI locations. Targeted at cancer patients and referring physicians needing advanced imaging.
  • Pain Management Specialized pain management services for cancer patients to address treatment-related pain and improve quality of life. Targeted at cancer patients experiencing pain from disease or treatment.
  • Palliative Medicine Palliative care services focused on symptom management and quality of life improvement for advanced cancer patients. Targeted at patients with advanced-stage disease requiring end-of-life and symptom-focused care.
  • Clinical Oncology Comprehensive clinical oncology services providing diagnosis, treatment planning, and management across all cancer types. Targeted at patients seeking end-to-end oncology clinical management.
  • Anaesthesia & Critical Care Anaesthesia and critical care services supporting complex oncology surgeries and ICU-level patient management. Targeted at patients undergoing major surgical oncology procedures and those requiring intensive care.
  • Cancer Screening Services Early detection and screening services for various cancer types to identify cancer at initial stages when treatment is most effective. Targeted at asymptomatic individuals and at-risk populations for preventive screening.
  • Second Opinion Service Expert second opinion consultations for cancer diagnosis and treatment planning, allowing patients to secure their health decisions with additional specialist input. Targeted at patients seeking confirmation or alternative treatment recommendations.
  • Online Consultation Digital consultation services allowing patients to connect with AOI oncologists remotely for initial assessments and follow-up consultations. Targeted at patients seeking remote specialist access.
  • International Patient Services Specialized services for international patients seeking cancer treatment in India, including treatment planning and coordination. Targeted at cross-border medical tourists seeking affordable, internationally-standardized oncology care.
  • Triple ICG Fluorescence-Guided Robotic Surgery Advanced robotic esophageal cancer surgery technique integrating Indocyanine Green (ICG) fluorescence navigation with robotic technology, providing real-time visualization of tumors, blood supply, and anatomical structures for precise tumor resections. Targeted at esophageal cancer patients requiring high-precision surgical oncology.

Quantifiable outcome

  • Real-time tumor visualization enabling more precise tumor resections with enhanced safety and oncological outcomes

Companies that use American Oncology Institute

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

American Oncology Institute technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

American Oncology Institute partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Alvarez & MarsalsupportingOthers · 13 May 2026Investment bank engaged by Siemens Healthineers to advise on the planned exit from American Oncology Institute, valued at ₹1,500-2,000 crore

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

American Oncology Institute competitors and assessment

Company assessment

Broad incumbents

  • Medanta - The Medicity: Major multi-specialty tertiary care hospital group with established cancer care programs including radiation oncology, surgical oncology, and BMT. Competes for complex oncology referrals in North India, with overlapping clinical capabilities but broader specialty mix than AOI.
  • Manipal Hospitals: One of India's largest hospital networks with multi-city presence and oncology service lines. Overlaps with AOI in metro and Tier-2 footprint and cancer care capabilities, but operates as a broad-spectrum health system rather than an oncology specialist.
  • Fortis Healthcare: Large multi-specialty hospital network in India with established oncology departments across multiple cities. Competes with AOI for cancer referrals, particularly in North India (Punjab, Haryana, NCR), but oncology is part of a broader hospital portfolio rather than the company's specialty focus.
  • Narayana Health: Large multi-specialty hospital chain with growing oncology services including the Mazumdar Shaw Cancer Centre. Competes with AOI on complex cancer care and price-value positioning, particularly in South India, though cancer is one of multiple specialties within a broader network.
  • Max Healthcare: Leading North India multi-specialty hospital chain with a dedicated oncology program serving the same geographies as AOI (Delhi NCR, Punjab, Haryana). Comparable on cancer care delivery, technology, and patient demographics, though oncology is one of several verticals.
  • Apollo Hospitals Enterprise: India's largest multi-specialty hospital chain with comprehensive oncology programs across many cities. Overlaps with AOI in radiation, medical, and surgical oncology and competes for the same complex cancer referrals, but operates as a broad incumbent rather than a cancer-only specialist.
  • Aster DM Healthcare: Multi-geography hospital and clinic operator with material India presence including oncology offerings. Comparable on hospital-based specialty care delivery and outpatient oncology revenue mix, but operates across multiple countries and verticals rather than focusing on cancer specialty.
  • Tata Memorial Hospital: Premier government-subsidized cancer specialty hospital in India, widely considered the gold standard for oncology care. Sets clinical reference protocols for the Indian oncology ecosystem and is a credible alternative to AOI, particularly for cost-sensitive patients, though operates on a public-subsidy model rather than for-profit commercial model.

Direct peers

  • Cytecare Cancer Hospitals: A focused oncology hospital chain in India providing multi-disciplinary cancer care (medical, surgical, radiation, hemato-oncology) with an organ-site specialty approach. Comparable to AOI as a specialty-only oncology network targeting similar patient segments and complexity tier.
  • Healthcare Global Enterprises (HCG): India's largest dedicated oncology hospital chain operating a multi-city network of cancer specialty hospitals with radiation, medical, and surgical oncology plus diagnostics. HCG is the closest direct competitor and has been approached as a strategic bidder for AOI, making it the most analogous operating model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

American Oncology Institute social profiles

Digital presence

American Oncology Institute financial estimates

Financial estimate

Revenue estimate

Valuation estimate

American Oncology Institute leadership team

Management profile

Number of profiles

Profiles2 records

American Oncology Institute funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

American Oncology Institute M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about American Oncology Institute

What does American Oncology Institute do?

American Oncology Institute (AOI) operates a multi-disciplinary oncology hospital network across South Asia, delivering comprehensive cancer diagnosis, treatment, and supportive care through 17 hospitals in India and Sri Lanka. Core offerings span radiation oncology, medical oncology, surgical oncology, hemato-oncology and bone marrow transplant, nuclear medicine, palliative care, and pain management. Services are delivered under US university-standardized clinical protocols, with centralized treatment planning, an International Tumor Board for complex cases, and advanced technologies including PET-CT imaging and robotic-assisted surgery.

Is American Oncology Institute a public or private company?

American Oncology Institute is a private company. It is classified as corporate owned and is currently operating.

When was American Oncology Institute founded?

American Oncology Institute was founded in 2012. It employs 1,001 to 5,000 people.

Where is American Oncology Institute based?

American Oncology Institute is headquartered in Hyderabad, India, in the Asia region.

How does American Oncology Institute make money?

Two revenue lines are on record. Cancer Treatment Services are the primary driver. The others are diagnostic Services.

Who are American Oncology Institute's main competitors?

Broad incumbents on record are Medanta - The Medicity, Manipal Hospitals, Fortis Healthcare, Narayana Health, Max Healthcare, Apollo Hospitals Enterprise, Aster DM Healthcare and Tata Memorial Hospital. Direct peers are Cytecare Cancer Hospitals and Healthcare Global Enterprises (HCG).

Does American Oncology Institute have an API?

No public API is recorded for American Oncology Institute.

What industry is American Oncology Institute in?

American Oncology Institute's product category is Oncology Hospital Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAKAFAB, Medical Oncology. Its NAICS code is 622310 and its SIC code is 8060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MintGA-Renova Hospitals may lead race to buy American Oncology Institute | Company Business NewsA consortium of General Atlantic and Renova Hospitals is in talks to acquire American Oncology Institute from Siemens Healthineers, with a deal potentially valued at ₹1,200-1,500 crore. Siemens has hired Alvarez & Marsal to advise on the divestiture, and other firms have evaluated the asset, but Renova is likely moving ahead with GA financing.MarketScreenerSiemens Healthineers Reportedly Plans To Exit American Oncology Institute In Transaction Valued at INR 15,000 Million To INR 20,000 MillionSiemens Healthineers is planning to exit its India-based American Oncology Institute in a transaction valued at INR 15,000 million to INR 20,000 million. The deal is being advised by Alvarez & Marsal, with HealthCare Global Enterprises and private equity funds among potential buyers. The divestment is part of a broader strategic review of its healthcare portfolio.The Times of IndiaSiemens eyes exit from cancer care chain American Oncology Institute - The Economic TimesSiemens Healthineers is planning to exit its Indian cancer care chain, American Oncology Institute (AOI), with the deal valued at ₹1,500-2,000 crore, according to sources aware of the development. Investment bank Alvarez & Marsal is advising on the transaction, with several private equity funds and Healthcare Global Enterprises (HCG) approached as potential bidders, and non-binding bids expected by end of June. AOI operates 16 hospitals across India and one in Sri Lanka, and sources indicate Siemens considers the chain a non-core asset.The HinduAOI Hyderabad introduces triple-fluorescence robotic surgery for esophageal cancerThe American Oncology Institute (AOI) in Hyderabad has introduced a triple-fluorescence robotic surgery technique for esophageal cancer, combining Indocyanine Green (ICG) fluorescence-guided navigation with robotic technology. The advancement was demonstrated during a robotic oesophagectomy performed on a 54-year-old patient from the United States who had a 1.5 cm adenocarcinoma at the gastroesophageal junction. The 'Triple ICG Strategy' provides real-time visualization of tumors, blood supply, and critical anatomical structures during surgery, enabling more precise tumor resections.